The 23-valent vaccine (Pneumo23) has a lower efficacy than Prevenar 13. It covers an additional 10 serotypes that are not covered by Prevenar 13. The vaccine authorities now recommend for groups at risk of invasive pneumococcal disease, such as persons aged 65 or above, chronic illness patients and the immunocompromised, for a broader coverage of serotypes. The vaccines are given in 1 to 4 doses depending on the age of recipient and individual vaccine history. Please consult our doctors for details.
Pneumococcus (Streptococcus pneumoniae, or S. pneumoniae)